Drug expected to cure sepsis fails phase three trial
By Steven Michael | March 22A clinical trial led by Steven Opal, professor of medicine at Alpert Medical School, found that the drug Eritoran was no more effective in treating sepsis than a placebo. The study was published in the Journal of the American Medical Association earlier this week. The study involved close to 2,000 ...